Navigation Links
WWMR, Inc. Announces New Website to Showcase Research Case Studies
Date:5/5/2008

SAN FRANCISCO, May 5 /PRNewswire/ -- Drawing on fifteen years of focused and solution-oriented research, WWMR, Inc. a leading strategic consultancy serving the Biotech, pharmaceutical, medical device and diagnostics industries, announces the launch of their new website showcasing more than 25 Research Case Study summaries. (http://www.wwmr.com).

WWMR, Inc. is a marketing research and strategic consulting firm with global capabilities, known for conducting focused and solution-oriented research across all phases of drug development.

Speaking on the occasion, Susan Olsen, President, WWMR, Inc., said that "Redesigning the website has provided us with an exciting opportunity to both provide content that will demonstrate the breadth of our capabilities, as well as educate those interested in learning about specific project approaches we've successfully carried out. We'd like to put our experience to work for those who may need to investigate drug development and launch topics that we have experience with."

The Custom Projects section of the new website lists appropriate types of marketing research for each stage of drug development, from Preclinical/Phase I through Launch. Attached to each type of research project is a document describing the Challenge, Solution and Impact for one or more projects. Specifics include descriptions of the scenario, objectives, and special challenges of the research, as well as the methodology and deliverables. To obtain more detail (which is available for each Case Study Summary), contact WWMR directly.

In support of its extensive services and growing client base, WWMR, Inc. has an experienced staff of Senior Consultants and Market Research Analysts. WWMR, Inc. also continues to expand its line of EP Publications over the coming year, with:

-- Pain Clinic Monitor -- a monthly audit of 100 carefully selected Pain

Clinics, reporting treatment details for 10 patients, as well as

detailing visits for up to five representatives.

-- 2008 U.S. Neuropathic Pain Report -- this fourth edition will feature

two new chapters -- Fibromyalgia and Neuropathic Cancer Pain.

The new website reaffirms WWMR, Inc.'s commitment to providing cost-effective business decision support to its pharmaceutical, Biotech, medical device and diagnostics clients who want to optimize the revenue potential of their product portfolio through effective business decisions.

WWMR, Inc. designs and executes research which brings clarity, reveals innovative opportunities and provides deeper understanding across all phases of drug development. This enables our clients to:

-- Demonstrate the commercial value of product/partnering opportunities

-- Optimize the revenue potential of their product portfolio

-- Identify and evaluate additional business opportunities

For more information about WWMR, Inc.'s services please contact Michelle Nordstrom, Office and Production Manager at the Corporate Headquarters:

WWMR, Inc.

2929 Campus Drive

Suite 200

San Mateo, CA 94403

Phone: (888) 947-2339

(650) 513-0300

Fax: (650) 312-1570

Web: http://www.WWMR.com

Email: Michelle_Nordstrom@WWMR.com


'/>"/>
SOURCE WWMR, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
2. Making the Outdoors Safer for Communities: the American Academy of Dermatology Announces 2008 AAD Shade Structure Program Grant Recipients
3. Herley Announces Settlement Agreement with U.S. Government
4. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
5. Authentidate Holding Corp. Announces Results From Annual Meeting of Stockholders
6. Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter
7. Lifetime Television Proudly Announces October Marquee Event Original Movie, Living Proof Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr.
8. Hear Indiana Announces Talk*Walk*Run 2008
9. Parkview Christian Center Announces September 2008 Opening of Outreach Ministry Building
10. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
11. AVEENO(R) Announces Sponsorship and Kick-Off of The Skin Cancer Foundations Road to Healthy Skin Tour Presented by AVEENO(R) and Rite Aid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... 2017 , ... Patients with missing teeth now have the ... from Dr. Alejandro Kovacs. Dr. Kovacs is a board-certified periodontist and prosthodontist who ... dental implants in Longview, TX. , During traditional dental implant ...
(Date:7/27/2017)... ... 27, 2017 , ... TransPanel Volume 4 is a collection of animating panel ... exclusive features transitions that contain between 2 and 6 animated panels. Change the direction ... menus. TransPanel Volume 4 makes editing easy in Final Cut Pro X. , TransPanel ...
(Date:7/27/2017)... Clara, CA (PRWEB) , ... July 27, 2017 ... ... announces the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution to ... support accelerated diagnostics and sleep care management. The speed and functionality of scoring ...
(Date:7/27/2017)... ... 2017 , ... SSCI, a division of Albany Molecular Research, ... representing a milestone achievement. , As an industry-leading provider of ... served as expert and fact witnesses to assist our clients to perform infringement ...
(Date:7/27/2017)... ... ... Angeles leg of the US movie premier of the Man in the Camo Jacket will ... Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the LA Live ... musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer and inspiring ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... July 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... its second quarter 2017 operating results on Monday, August ... to follow at 5:00 p.m. ET. ... to a live broadcast of the conference call by ... participant code 51641230 approximately 15 minutes prior to the ...
(Date:7/20/2017)... 2017  Prime Therapeutics LLC (Prime) released this statement from ... today,s Institute for Clinical and Economic Review,s (ICER) public ... and value of abuse-deterrent formulations (ADF) of opioids. Prime was ... the meeting. "The ... to the use of abuse-deterrent formulations (ADF) in opioids in ...
(Date:7/14/2017)... VEGAS , July 13, 2017 It should ... United States is in the midst of a ... Control , since 1999, the number of overdose deaths from ... "resulting in over half a million dead from 2001 to ... codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling ...
Breaking Medicine Technology: